Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

18F-FAPI PET/CT and 18F-FDG PET/CT in Patients With Pancreatic Adenocarcinoma : A Prospective, Single-Center, Comparative Study

NCT05884463 is registered in ClinicalTrials.gov with Zhejiang University as lead sponsor.

NCT NCT05884463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05884463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
18F-FAPI PET/CT and 18F-FDG PET/CT in Patients With Pancreatic Adenocarcinoma : A Prospective, Single-Center, Comparative Study
Lead sponsor
Zhejiang University
Phase
Not applicable
Overall status
Completed
Start date
April 1, 2021
Completion date
February 28, 2023
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

18f-fapi, 18f-fdg, diagnosis, pancreas adenocarcinoma, staging